Montelukast Sodium
NDC 57237-213, Montelukast Sodium, tablet, chewable, from Rising Pharma Holdings, Inc..
- Product NDC
- 57237-213
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202096
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/57237-213 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MONTELUKAST SODIUM5 mg/1
Pharmacologic classes
Leukotriene Receptor Antagonist [EPC]; Leukotriene Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57237-213-30 | 57237021330 | 30 TABLET, CHEWABLE in 1 BOTTLE (57237-213-30) |
| 57237-213-90 | 57237021390 | 90 TABLET, CHEWABLE in 1 BOTTLE (57237-213-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/49669ac0-0bb5-4576-bed5-9e85e0d76a44NADAC price for package 57237021330
GET /v1/drugs/nadac/57237021330NADAC price for package 57237021390
GET /v1/drugs/nadac/57237021390
Use it
Look up 57237-213 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57237-213 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57237-213. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.